General ControlFounder and CEO
Until Present
Lada Nuzhna founded General Control to develop durable, reversible multi-gene epigenetic medicines for age-related disease. Previously, she co-founded Impetus Grants, which raised and allocated more than $34 million for aging research.
Lada Nuzhna founded General Control to develop durable, reversible multi-gene epigenetic medicines for age-related disease. Previously, she co-founded Impetus Grants, which raised and allocated more than $34 million for aging research.
Career
Impetus GrantsCo-founder and Program Director
2021 — 2024
Cosigns Received
Featured Media
generalcontrol.inc
General Control’s Vision for Epigenetic Medicines
The company’s thesis for programmable therapies that coordinate gene expression across complex age-related disease networks.
youtube.com
The Next Trillion-Dollar Aging Company
Nuzhna discusses biotech’s downturn and how AI and new therapeutic modalities could reshape aging research.
corememory.com
A New Bid to Control the Genome
Ashlee Vance profiles Nuzhna and General Control’s approach to multiplexed epigenetic editing.